Last updated: 2026-10-05 10:32:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
ZOETIS INC. (ZTS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $69.73, with a market capitalization of $28.80B and a P/E ratio of 11.01. Over the past 52 weeks, its price has ranged from $68.77 to $148.30. This page covers its latest market performance, valuation, price trends and company information.
$28.80B | |
$69.69 | |
$249.27 | |
$28.14 | |
$69.69 | |
1.64K | |
5.51M | |
11.01 | |
$148.30 | |
$68.77 | |
3.09% | |
-- |
ZOETIS INC. (ZTS) is trading at $69.73 in pre-market trading as of 2026-10-05 10:23:00, up 0.05% ($0.03) from the previous close of $69.69
Pre-market trading shows how investors are pricing ZTS before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, ZOETIS INC. (ZTS) moved from $70.27 to $69.73, representing a decline of 0.78% ($0.55).
The stock traded between $68.77 and $72.38 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 4.29 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.2%
ZTS is currently trading at $69.73, placing it 1.2% of the way from its 52-week low of $68.77 to its 52-week high of $148.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 14500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of ZOETIS INC. (ZTS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.